Profile of viral load, integration, and E2 gene disruption of HPV58 in normal cervix and cervical neoplasia.

The clinical utility of viral-load and integration status of human papillomavirus (HPV) infection remains uncertain. We examined 75 women infected with HPV58, a worldwide rare type found to be prevalent in cervical cancers in eastern Asia. Viral load was significantly higher for cervical intraepithelial neoplasia (CIN) 1/2, but those for a normal control group and for CIN 3 or cancer overlapped substantially. A pure integrated genome was found for all lesion grades, giving a poor positive predictive value (23.1%) for cancer. The pure episomal form's negative predictive value for cancer was only 76.3%. Mixed patterns of E2 gene disruption were common and often involved the amino-terminal and hinge regions. Disruption of the whole E2 gene was rare and was restricted to high-grade lesions. The HPV58 variant E67-HK-2 was more likely to exist in the pure episomal form. Routinely collected cervical samples contain a heterogeneous population of viruses, hampering the application of viral load and integration testing in clinical settings.

[1]  Yongge Wu,et al.  HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China. , 2007, Gynecologic oncology.

[2]  J. Tang,et al.  Viral load, E2 gene disruption status, and lineage of human papillomavirus type 16 infection in cervical neoplasia. , 2006, The Journal of infectious diseases.

[3]  C. Cuvelier,et al.  Prevalence of high risk human papillomavirus types among Nicaraguan women with histological proved pre-neoplastic and neoplastic lesions of the cervix , 2006, Sexually Transmitted Infections.

[4]  Shih-hung Huang,et al.  Integrated human papillomavirus types 52 and 58 are infrequently found in cervical cancer, and high viral loads predict risk of cervical cancer. , 2006, Gynecologic oncology.

[5]  S. Franceschi,et al.  Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study , 2006, British Journal of Cancer.

[6]  C. Peyton,et al.  Human Papillomavirus Type 16 Integration in Cervical Carcinoma In Situ and in Invasive Cervical Cancer , 2006, Journal of Clinical Microbiology.

[7]  J. Doorbar,et al.  Molecular biology of human papillomavirus infection and cervical cancer. , 2006, Clinical science.

[8]  C. Chou,et al.  The distribution and differential risks of human papillomavirus genotypes in cervical preinvasive lesions: a Taiwan Cooperative Oncologic Group Study , 2006, International Journal of Gynecologic Cancer.

[9]  S. Nieh,et al.  Differential viral loads of human papillomavirus 16 and 58 infections in the spectrum of cervical carcinogenesis , 2005, International Journal of Gynecologic Cancer.

[10]  P. Chan,et al.  Biases in human papillomavirus genotype prevalence assessment associatedwith commonly used consensus primers , 2006, International journal of cancer.

[11]  U. Gyllensten,et al.  Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN) , 2005, British Journal of Cancer.

[12]  N. Nagelkerke,et al.  Can viral load, semi-quantitatively evaluated, of human papillomavirus predict cytological or histological outcome in women with atypical squamous or glandular cells of undetermined significance cytology? , 2005, European journal of gynaecological oncology.

[13]  A. Biri,et al.  Assessment of human papilloma viral load of archival cervical intraepithelial neoplasia by real-time polymerase chain reaction in a Turkish population. , 2005, European journal of gynaecological oncology.

[14]  M. Grace,et al.  Mechanisms of Human Papillomavirus-Induced Oncogenesis , 2004, Journal of Virology.

[15]  E. Kubista,et al.  Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. , 2004, Gynecologic oncology.

[16]  M. Puerto-Solís,et al.  High prevalence of human papillomavirus type 58 in Mexican colposcopy patients. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[17]  C. R. Martins,et al.  Prevalence of human papillomavirus types in women with pre-neoplastic and neoplastic cervical lesions in the Federal District of Brazil. , 2003, Memorias do Instituto Oswaldo Cruz.

[18]  F. X. Bosch,et al.  Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.

[19]  M. Plummer,et al.  Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis , 2003, British Journal of Cancer.

[20]  P. Chan,et al.  Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in southern China. , 2002, The Journal of infectious diseases.

[21]  P. Chan,et al.  Association of human papillomavirus type 58 variant with the risk of cervical cancer. , 2002, Journal of the National Cancer Institute.

[22]  A. Venuti,et al.  HPV16 and HPV18 in genital tumors: Significantly different levels of viral integration and correlation to tumor invasiveness , 2002, Journal of medical virology.

[23]  A. Teyssié,et al.  Physical status of the E2 human papilloma virus 16 viral gene in cervical preneoplastic and neoplastic lesions. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[24]  P. Chan,et al.  High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions , 1999, Journal of medical virology.

[25]  J. Peto,et al.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.

[26]  W. Reeves,et al.  Human Papillomavirus (HPV) DNA Copy Number Is Dependent on Grade of Cervical Disease and HPV Type , 1999, Journal of Clinical Microbiology.

[27]  R. Holm,et al.  Disruption of the E1 and E2 Reading Frames of HPV 16 in Cervical Carcinoma Is Associated with Poor Prognosis , 1998, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[28]  V. Giaché,et al.  Analysis of HPV16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix. , 1997, Journal of clinical pathology.

[29]  Chien-Jen Chen,et al.  Human papillomavirus types 52 and 58 are prevalent in cervical cancer from Chinese women , 1997, International journal of cancer.

[30]  P. Lambert,et al.  Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells , 1995, Journal of virology.

[31]  P. Lambert,et al.  Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Cuzick,et al.  Semi‐quantitative human papillomavirus DNA detection in the management of women with minor cytological abnormality , 1994, British journal of obstetrics and gynaecology.

[33]  J. Cuzick,et al.  Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. , 1994, British Journal of Cancer.